SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE_02_085700101 | chr7:32963472-33021074![]() |
Sample_02_0857 | Glioblastoma | Glioblastoma neurosphere cell_HF-3035 | 101 | 13 | 1505 | 207 | 1 | 132 | 1184 | FKBP9,NT5C3A,RP9P |
SE_02_077600258 | chr7:33023728-33064060![]() |
Sample_02_0776 | Pancreas | EndoC-BH1 | 258 | 10 | 1028 | 159 | 1 | 66 | 544 | NT5C3A,FKBP9,RP9 |
SE_02_077501487 | chr7:33024821-33055347![]() |
Sample_02_0775 | Pancreas | EndoC-BH1_SE | 1487 | 10 | 786 | 123 | 1 | 50 | 290 | NT5C3A,FKBP9 |
SE_02_142901184 | chr7:33029998-33063649![]() |
Sample_02_1429 | Blood | GM12878_WT | 1184 | 12 | 871 | 129 | 1 | 62 | 419 | NT5C3A,RP9 |
SE_02_072400278 | chr7:33034227-33050723![]() |
Sample_02_0724 | Pancreatic duct | AsPC1_GFP_DOX | 278 | 6 | 448 | 61 | 1 | 42 | 197 | NT5C3A |
SE_02_070500292 | chr7:33034230-33050753![]() |
Sample_02_0705 | Pancreas | AsPC1 WT | 292 | 7 | 449 | 62 | 1 | 42 | 197 | NT5C3A |
SE_02_103400386 | chr7:33034230-33063837![]() |
Sample_02_1034 | Blood | AML cell | 386 | 5 | 770 | 112 | 1 | 62 | 419 | NT5C3A,RP9 |
SE_02_070900933 | chr7:33034246-33050679![]() |
Sample_02_0709 | Pancreas | hT85_organoid | 933 | 6 | 447 | 61 | 1 | 42 | 197 | NT5C3A |
SE_02_136500967 | chr7:33034266-33050819![]() |
Sample_02_1365 | Pancreas | AsPC1-untreated | 967 | 6 | 449 | 63 | 1 | 42 | 197 | NT5C3A |
SE_02_072000225 | chr7:33034266-33050857![]() |
Sample_02_0720 | Pancreas | AsPC1_TP63dN_DOX | 225 | 5 | 451 | 64 | 1 | 43 | 197 | NT5C3A |
SE_02_072100753 | chr7:33034368-33054930![]() |
Sample_02_0721 | Pancreas | HPAFII_TP63dN_DOX | 753 | 4 | 542 | 77 | 1 | 48 | 197 | NT5C3A |
SE_02_071900573 | chr7:33034369-33055197![]() |
Sample_02_0719 | Pancreas | SUIT2_TP63dN_DOX | 573 | 9 | 551 | 78 | 1 | 48 | 197 | NT5C3A |
SE_02_070300417 | chr7:33034417-33046135![]() |
Sample_02_0703 | Pancreas | PATU8988S WT | 417 | 4 | 325 | 52 | 0 | 40 | 197 | NT5C3A |
SE_02_071000470 | chr7:33034843-33050713![]() |
Sample_02_0710 | Pancreas | hN34_organoid | 470 | 4 | 427 | 59 | 1 | 42 | 197 | NT5C3A |
SE_02_130400869 | chr7:33037450-33062762![]() |
Sample_02_1304 | Lymphoma | RL_lenalidomide_tazemetostat | 869 | 9 | 653 | 85 | 1 | 42 | 176 | NT5C3A,RP9 |
SE_02_048101626 | chr7:33038235-33073468![]() |
Sample_02_0481 | Mammary gland | MDA-MB231 | 1626 | 8 | 906 | 114 | 3 | 43 | 312 | NT5C3A,RP9 |
SE_02_061700965 | chr7:33038572-33060580![]() |
Sample_02_0617 | HSPC | FL CD34+CD38-/lowCD90+ HSPC | 965 | 6 | 562 | 74 | 1 | 30 | 90 | NT5C3A,RP9 |
SE_02_071600682 | chr7:33038862-33054887![]() |
Sample_02_0716 | Pancreas | SUIT2_GFP | 682 | 7 | 417 | 52 | 1 | 29 | 74 | NT5C3A |
SE_02_071100877 | chr7:33038863-33050756![]() |
Sample_02_0711 | Pancreas | hN35_organoid | 877 | 4 | 322 | 37 | 1 | 23 | 74 | NT5C3A |
SE_02_084200268 | chr7:33038895-33054810![]() |
Sample_02_0842 | Umbilical cord blood | HSPC-derived early erythroid progenitors | 268 | 7 | 415 | 52 | 1 | 29 | 74 | NT5C3A |
SE_02_082000323 | chr7:33039032-33056204![]() |
Sample_02_0820 | Haematopoietic and lymphoid tissue | SET-2_WT_DMSO | 323 | 3 | 452 | 58 | 1 | 29 | 67 | NT5C3A |
SE_02_049401086 | chr7:33041967-33046234![]() |
Sample_02_0494 | Islets | differentiated hESCs Late pancreatic progenitor cells | 1086 | 2 | 125 | 15 | 0 | 2 | 0 | NT5C3A |
SE_02_049501007 | chr7:33042315-33045584![]() |
Sample_02_0495 | Islets | differentiated hESCs Early LSD1 inhibition PP2 | 1007 | 1 | 89 | 12 | 0 | 2 | 0 | NT5C3A |
SE_02_048400668 | chr7:33049969-33057095![]() |
Sample_02_0484 | Bone marrow | HSCe_23y_CD34+,CD38-,Lineage- | 668 | 6 | 174 | 26 | 0 | 7 | 0 | NT5C3A |
SE_02_048300499 | chr7:33050353-33055176![]() |
Sample_02_0483 | Bone marrow | HSCe_22y_CD34+,CD38-,Lineage- | 499 | 4 | 113 | 17 | 0 | 7 | 0 | NT5C3A |